Retirement Systems of Alabama Has $20.64 Million Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Retirement Systems of Alabama lifted its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 0.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 215,084 shares of the company’s stock after buying an additional 481 shares during the quarter. Retirement Systems of Alabama owned about 0.25% of HealthEquity worth $20,637,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the business. GDS Wealth Management boosted its stake in HealthEquity by 43.6% in the fourth quarter. GDS Wealth Management now owns 41,131 shares of the company’s stock valued at $3,947,000 after acquiring an additional 12,493 shares during the last quarter. Greenleaf Trust acquired a new position in shares of HealthEquity in the 4th quarter valued at $214,000. KBC Group NV boosted its position in shares of HealthEquity by 56.7% in the 4th quarter. KBC Group NV now owns 3,860 shares of the company’s stock worth $370,000 after purchasing an additional 1,397 shares during the last quarter. Curated Wealth Partners LLC acquired a new stake in shares of HealthEquity during the fourth quarter worth $242,000. Finally, Exchange Traded Concepts LLC increased its holdings in HealthEquity by 2.6% in the fourth quarter. Exchange Traded Concepts LLC now owns 9,813 shares of the company’s stock valued at $942,000 after purchasing an additional 245 shares during the last quarter. 99.55% of the stock is owned by institutional investors.

Insider Transactions at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of the stock in a transaction on Monday, December 9th. The shares were sold at an average price of $101.56, for a total value of $837,870.00. Following the completion of the sale, the director now owns 66,469 shares in the company, valued at $6,750,591.64. This trade represents a 11.04 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Stuart B. Parker sold 25,000 shares of HealthEquity stock in a transaction dated Thursday, December 12th. The shares were sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the completion of the transaction, the director now directly owns 19,061 shares of the company’s stock, valued at approximately $1,843,579.92. This trade represents a 56.74 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 2.20% of the company’s stock.

HealthEquity Stock Up 0.1 %

Shares of HealthEquity stock opened at $112.07 on Friday. The firm has a market cap of $9.71 billion, a PE ratio of 102.82, a P/E/G ratio of 1.94 and a beta of 0.55. The business’s 50 day simple moving average is $100.77 and its 200 day simple moving average is $89.34. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $113.22.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same quarter in the prior year, the business posted $0.40 earnings per share. On average, analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of analysts have recently commented on the company. Bank of America upped their price target on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. The Goldman Sachs Group began coverage on shares of HealthEquity in a research note on Friday, November 15th. They issued a “neutral” rating and a $108.00 target price for the company. JMP Securities lifted their price target on shares of HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research report on Tuesday, December 10th. Mizuho started coverage on shares of HealthEquity in a report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price target for the company. Finally, BTIG Research raised their price objective on HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research note on Thursday, November 14th. One equities research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $110.71.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.